Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Qiagen and Roche Bury the Hatchet on Dispute over DxS TheraScreen Assay Distribution

Roche retains existing distribution rights to KRAS and EGFR assays, while Qiagen will market products under its own label.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »